$2.230
-0.039 (-1.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BDTX Prediction & Forecast by Similar Chart Analysis
Alphio's BDTX stock price prediction model matches the current Black Diamond Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.23 (-0.17%). The 1-week path is $2.24 (+0.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Black Diamond Therapeutics Inc Stock?
Black Diamond Therapeutics Inc is a good buy right now due to its recent positive clinical trial results and strong analyst support. The current price is $2.23, with a forward P/E ratio of 8.33, suggesting that the stock is undervalued compared to future earnings potential. Additionally, the RSI is at 63.71, indicating bullish momentum. However, investors should be cautious of the recent 35.8% drop in stock price following mixed Phase II results, which reflects market volatility and uncertainty.
BDTX stock price ended at $2.23 on Friday, after losing -1.76%
Black Diamond Therapeutics Inc (BDTX) last closed at $2.23, losing -1.76%. These facts feed the 1-day and 1-week BDTX price prediction above.
Forecast Drivers
Black Diamond Therapeutics Inc (BDTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BDTX, ranked by similarity.
Seasonality analysis for BDTX
Historically the probability of a positive August return for BDTX is 68.25%. September offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BDTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.39 | $2.84 | $2.92 | +27.24% |
| Sep 2026 | $3.32 | $3.78 | $4.26 | +69.48% |
| Oct 2026 | $2.52 | $2.96 | $3.09 | +32.84% |
| Nov 2026 | $3.63 | $3.74 | $3.76 | +67.93% |
| Dec 2026 | $2.48 | $2.91 | $3.20 | +30.60% |
In 2026, Black Diamond Therapeutics Inc (BDTX) is projected to range from $2.39 to $4.26.
Black Diamond Therapeutics Inc 2026 monthly forecast
In Aug 2026, Black Diamond Therapeutics Inc is projected to average $2.84, with a low of $2.39 and high of $2.92.
In Sep 2026, Black Diamond Therapeutics Inc is projected to average $3.78, with a low of $3.32 and high of $4.26.
In Oct 2026, Black Diamond Therapeutics Inc is projected to average $2.96, with a low of $2.52 and high of $3.09.
In Nov 2026, Black Diamond Therapeutics Inc is projected to average $3.74, with a low of $3.63 and high of $3.76.
In Dec 2026, Black Diamond Therapeutics Inc is projected to average $2.91, with a low of $2.48 and high of $3.20.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.